|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CURON MEDICAL INC, 10-Q, 2000-11-14 |
Next: UBS AG, 8-A12B, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 43,059
<SECURITIES> 8,024
<RECEIVABLES> 502
<ALLOWANCES> 0
<INVENTORY> 662
<CURRENT-ASSETS> 52,751
<PP&E> 2,361
<DEPRECIATION> (899)
<TOTAL-ASSETS> 55,072
<CURRENT-LIABILITIES> 1,620
<BONDS> 0
0
0
<COMMON> 19
<OTHER-SE> 53,385
<TOTAL-LIABILITY-AND-EQUITY> 55,072
<SALES> 856
<TOTAL-REVENUES> 856
<CGS> 1,141
<TOTAL-COSTS> 1,141
<OTHER-EXPENSES> 10,430
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4,087
<INCOME-PRETAX> (14,269)
<INCOME-TAX> 0
<INCOME-CONTINUING> (14,269)
<DISCONTINUED> 0
<EXTRAORDINARY> 1,596
<CHANGES> 0
<NET-INCOME> (12,673)
<EPS-BASIC> (4.02)
<EPS-DILUTED> (4.02)
</TABLE>
|
|